Skip main navigation

Military Health System

Hurricane Milton & Hurricane Helene

Emergency procedures are in place in multiple states due to Hurricane Milton & Hurricane Helene. >>Learn More

Protect Your Family With Flu, COVID-19, and RSV Vaccines

Image of Protect Your Family With Flu, COVID-19, and RSV Vaccines. Leaders and Soldiers receive their influenza vaccination as the annual flu shot campaign kicks off, at the U.S. Army Aviation Center of Excellence headquarters at Fort Novosel, Ala., October 18, 2023. (U.S. Army photo by Kelly Morris)

FALLS CHURCH, Va. – Are you preparing to spend time with friends and family this holiday season? Now is a good time to make sure you and your loved ones are up to date with COVID-19, flu, and RSV vaccines. TRICARE covers these vaccines based on Centers for Disease Control and Prevention (CDC) recommendations.

“Vaccination against flu, COVID-19, and RSV offers the best protection from serious illness caused by these diseases,” said Capt. John Iskander, MD, MPH, chief, Immunization Healthcare Division, Defense Health Agency. “People ages 6 months and older should get the seasonal flu vaccine and updated COVID-19 vaccine. Certain people, including older adults, pregnant people, and infants, can get vaccinated against RSV.” Read on to learn about the vaccines recommended for you and where to get them.

Flu and COVID-19 Vaccines

Flu and COVID-19 are contagious diseases that affect millions of Americans each year. These diseases can cause severe illness, hospitalization, and even death. The seasonal flu vaccine and the updated COVID-19 vaccine can help reduce these risks. The updated COVID-19 vaccine can also reduce your risk of developing Long COVID.

The CDC recommends that everyone ages 6 months and older get vaccinated against flu and COVID-19. This year’s flu vaccine is available as a flu shot or nasal spray. COVID-19 vaccines from Moderna, Pfizer-BioNTech, and Novavax have all been updated for the 2023-2024 season. The types of flu and COVID-19 vaccines you can get are based on your age and other factors. Your health care provider can help you decide which options are best for you.

RSV Vaccines

RSV is a common respiratory virus that usually causes mild, cold-like symptoms. However, infants and older adults are more likely to develop severe RSV. This can lead to hospitalization.

TRICARE covers RSV vaccines for certain people, based on CDC recommendations:

  • All infants younger than 8 months
  • Infants and children ages 8 to 19 months at increased risk for developing severe RSV
  • Adults ages 60 and older
  • Pregnant people during weeks 32 through 36 of pregnancy

Where Can I Get Vaccinated?

There are three ways you can get these vaccines at no cost:

  1. Go to a military hospital or clinic. Call ahead to make sure the vaccine is available.
  2. Go to a TRICARE retail network pharmacy. Make sure the person who gives you the vaccine is a pharmacist. If another type of provider gives you a vaccine at a participating pharmacy, you may have out-of-pocket costs.
  3. See a TRICARE-authorized provider. However, if you get other services at the same time, you may have to pay copayments or cost-shares. These costs vary based on your health plan.

You can get the flu, COVID-19, and RSV vaccines recommended for you at the same time.

Talk to your provider if you have questions about vaccines. For more info on vaccine coverage, check out Immunizations.

Would you like the latest TRICARE news sent to you by email? Visit TRICARE Subscriptions, and create your personalized profile to get benefit updates, news, and more.

You also may be interested in...

Article
Sep 23, 2024

Military Infectious Diseases Research Program Focuses on Mitigating Disease Impacts in Large Scale Combat Operations

U.S. Army Staff Sgt. Matthew Pascual, a preventive medicine specialist with the Walter Reed Army Institute of Research Armed Forces Research Institute of Medical Sciences, processes samples for respiratory virus testing at Nimmarnkolayut Camp, Sa Kaeo, Thailand.

Prolonged care, degraded medical evacuation capability, and overstretched lines of communication during large-scale combat operations could increase the prevalence of disease-related injury and death among warfighters. These risks are what the U.S. Army Medical Research and Development Command's Military Infectious Diseases Research Program is working ...

Publication
Sep 3, 2024

Immunization Tool Kit 9th Edition

.PDF | 7.47 MB

A practical reference that facilitates and enhances the global delivery of quality immunization healthcare to Department of Defense beneficiaries and employees. The Defense Health Agency Immunization Healthcare Division publishes the Immunization Tool Kit based on national recommendations, evidenced-based, peer-reviewed published medical literature, ...

Topic
Aug 29, 2024

Vaccines

Vaccines are critical tools in the health care arsenal, with a long, successful history of fighting or eradicating disease. Vaccines have saved more lives around the world than any other medical invention.

Article
Aug 27, 2024

WRAIR Researchers Discuss Vaccine Innovations at MHSRS

Dr. Essie Komla of the U.S. Army Medical Research and Development Command’s Walter Reed Army Institute of Research discusses research conducted by WRAIR in partnership with the Henry Jackson Foundation for the Advancement of Military Medicine to test the effectiveness of vaccines containing a new variant of the Army Liposome Formulation family of adjuvants in combating HIV, malaria, SARS-CoV-2, and Campylobacter.

Researchers from the U.S. Army Medical Research and Development Command’s Walter Reed Army Institute of Research shared their work to develop innovative approaches for preventing and treating infectious diseases of national security importance to the U.S. military, including HIV, malaria, and coronaviruses.

Topic
Sep 3, 2024

Immunization Healthcare Division

The DHA Immunization Healthcare Division supports all DOD immunization programs, and provides clinical consultative services, educational support, and training resources for the entire DOD family.

Article
Mar 1, 2024

Mid-Season Influenza Vaccine Effectiveness Estimates Among DOD Populations: A Composite of Data Presented at VRBPAC—the Vaccines and Related Biological Products Advisory Committee—2024 Meeting on Influenza Vaccine Strain Selection for the 2024-2025 Influenza Season

This is an introduction to a composite of three Surveillance Snapshots of Department of Defense data on mid-season influenza vaccine effectiveness that were presented at the 2024 VRBPAC meeting.

Skip subpage navigation
Refine your search
Last Updated: April 25, 2024
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on X Follow us on YouTube Sign up on GovDelivery